Pediatrics

Accelerating the development of safe and effective treatments for children and adolescents

Leverage our deep understanding of the diverse populations—spanning preterm infants to adolescents—to guide your pediatric research.

Address the needs of pediatric patients and their families across your development journey with our extensive regulatory, medical and operational expertise.

Speed up your pediatric drug development plan with our best practices to efficiently enroll adolescents and young adult populations into your pivotal trials.

Pediatric patients and their families are at the center of all we do

Participating in a pediatric trial requires a huge commitment not just from a patient, but also from their family. That’s why our pediatric experts at Fortrea work to develop tailored solutions that address specific study considerations, minimize the burden of participation and support successful study conduct.

At Fortrea, we share your passion to make a difference in patients’ lives. You’ll get a partner that:

Understands the nuances of pediatric research
Offers longstanding experience designing, planning and conducting pediatric programs
Delivers the collective knowledge of 34 pediatricians and more than 2,400 employees experienced with pediatric populations

Together, let’s address the inherent challenges of pediatric studies and navigate the best path ahead.

Experience matters when choosing a partner

Let's Connect

In the last 5 years

Across all phases of development, many indications and all pediatric age groups, we’ve been honored to serve as a CRO partner of choice for our biotech and pharmaceutical customers.

380

Pediatric projects in total

233

Rare disease projects involving pediatric populations

Advanced therapy projects (including cell and gene therapy) involving pediatric populations

Oncology & Hematology

Endocrinology & Metabolism

Neuroscience

Infectious Disease

Cardiovascular & Pulmonary

Get the latest updates from our pediatric experts

We're sharing our latest news, events, and publications.

White paper

Incorporating the voice of patients in pediatric assent forms

Read the article

Blog

Learn about the experiences of the young participants involved in the clinical trials

Read blog article

WHITE PAPER

Enrolling adolescents into adult clinical trials

Read the white paper

We’re committed to bringing clinical research to all

As your partner, we can work as an extension of your team and:

Develop and execute your pediatric regulatory strategy and provide consulting to support your PIP and iPSP
Provide pediatric program development and study design including protocol writing
Enable custom strategy and planning for your program including feasibility, optimal country and site selection
Create relevant patient and family facing materials including assent/ consent for the different pediatric age groups
Collaborate with relevant advocacy groups, such as the International Children’s Advisory Network (iCAN)

Serving as your agile partner for complex and novel clinical trials

Let our multidisciplinary experts put their experience to work to advance your pediatric drug development program and transform obstacles into opportunities. Together, we’ll improve your potential for success and make a difference in urgent unmet medical needs.

Explore our related areas of expertise.

Cell and Gene Therapies Rare Diseases Our Team (RAPT)

Your needs. Our solutions.

As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma and medical device and diagnostic companies to drive healthcare innovation throughout the world.